ReP USP - Resultado da busca

Artigo de periodico
The complosome - a key regulator of hematopoietic stem cells and innate immune responses (2025)
Ulrich, Henning
Source: Leukemia. Unidade: IQ
Subjects: CÉLULAS-TRONCO, PROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ULRICH, Henning. The complosome - a key regulator of hematopoietic stem cells and innate immune responses. Leukemia, v. 39, p. 2297–2298, 2025Tradução . . Disponível em: https://dx.doi.org/10.1038/s41375-025-02728-x. Acesso em: 18 abr. 2026.
APA
Ulrich, H. (2025). The complosome - a key regulator of hematopoietic stem cells and innate immune responses. Leukemia, 39, 2297–2298. doi:10.1038/s41375-025-02728-x
NLM
Ulrich H. The complosome - a key regulator of hematopoietic stem cells and innate immune responses [Internet]. Leukemia. 2025 ; 39 2297–2298.[citado 2026 abr. 18 ] Available from: https://dx.doi.org/10.1038/s41375-025-02728-x
Vancouver
Ulrich H. The complosome - a key regulator of hematopoietic stem cells and innate immune responses [Internet]. Leukemia. 2025 ; 39 2297–2298.[citado 2026 abr. 18 ] Available from: https://dx.doi.org/10.1038/s41375-025-02728-x
Artigo de periodico
Patient-reported outcomes in Philadelphia chromosome-positive acute lymphoblastic leukemia patients treated with ponatinib or imatinib: results from the PhALLCON trial (2025)
Ashaye, Ajibade; Shi, Ling; Aldoss, Ibrahim; Montesinos, Pau; Vachhani, Pankit; Rocha, Vanderson Geraldo ; Papayannidis, Cristina; Leonard, Jessica T.; Baer, Maria R.; Ribera, Jose-Maria
Source: Leukemia. Unidade: FM
Subjects: LEUCEMIA, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ASHAYE, Ajibade et al. Patient-reported outcomes in Philadelphia chromosome-positive acute lymphoblastic leukemia patients treated with ponatinib or imatinib: results from the PhALLCON trial. Leukemia, v. 39, n. 6, p. 1342-1350, 2025Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/87063. Acesso em: 18 abr. 2026.
APA
Ashaye, A., Shi, L., Aldoss, I., Montesinos, P., Vachhani, P., Rocha, V. G., et al. (2025). Patient-reported outcomes in Philadelphia chromosome-positive acute lymphoblastic leukemia patients treated with ponatinib or imatinib: results from the PhALLCON trial. Leukemia, 39( 6), 1342-1350. doi:10.1038/s41375-025-02608-4
NLM
Ashaye A, Shi L, Aldoss I, Montesinos P, Vachhani P, Rocha VG, Papayannidis C, Leonard JT, Baer MR, Ribera J-M. Patient-reported outcomes in Philadelphia chromosome-positive acute lymphoblastic leukemia patients treated with ponatinib or imatinib: results from the PhALLCON trial [Internet]. Leukemia. 2025 ; 39( 6): 1342-1350.[citado 2026 abr. 18 ] Available from: https://observatorio.fm.usp.br/handle/OPI/87063
Vancouver
Ashaye A, Shi L, Aldoss I, Montesinos P, Vachhani P, Rocha VG, Papayannidis C, Leonard JT, Baer MR, Ribera J-M. Patient-reported outcomes in Philadelphia chromosome-positive acute lymphoblastic leukemia patients treated with ponatinib or imatinib: results from the PhALLCON trial [Internet]. Leukemia. 2025 ; 39( 6): 1342-1350.[citado 2026 abr. 18 ] Available from: https://observatorio.fm.usp.br/handle/OPI/87063
Artigo de periodico
The P2X4 purinergic receptor has emerged as a potent regulator of hematopoietic stem/progenitor cell mobilization and homing-a novel view of P2X4 and P2X7 receptor interaction in orchestrating stem cell trafficking (2022)
Adamiak, Mateusz ; Bujko, Kamila ; Thapa, Arjun; Pensato, Valentina; Janus, Katarzyna Brzezniakiewicz ; Ratajczak, Janina; Davies, Daryl L ; Ulrich, Henning ; Kucia, Magda ; Ratajczak, Mariusz Z
Source: Leukemia. Unidade: IQ
Subjects: CÉLULAS-TRONCO, ADENOSINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ADAMIAK, Mateusz et al. The P2X4 purinergic receptor has emerged as a potent regulator of hematopoietic stem/progenitor cell mobilization and homing-a novel view of P2X4 and P2X7 receptor interaction in orchestrating stem cell trafficking. Leukemia, v. 36, n. 1, p. 248-256, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41375-021-01352-9. Acesso em: 18 abr. 2026.
APA
Adamiak, M., Bujko, K., Thapa, A., Pensato, V., Janus, K. B., Ratajczak, J., et al. (2022). The P2X4 purinergic receptor has emerged as a potent regulator of hematopoietic stem/progenitor cell mobilization and homing-a novel view of P2X4 and P2X7 receptor interaction in orchestrating stem cell trafficking. Leukemia, 36( 1), 248-256. doi:10.1038/s41375-021-01352-9
NLM
Adamiak M, Bujko K, Thapa A, Pensato V, Janus KB, Ratajczak J, Davies DL, Ulrich H, Kucia M, Ratajczak MZ. The P2X4 purinergic receptor has emerged as a potent regulator of hematopoietic stem/progenitor cell mobilization and homing-a novel view of P2X4 and P2X7 receptor interaction in orchestrating stem cell trafficking [Internet]. Leukemia. 2022 ; 36( 1): 248-256.[citado 2026 abr. 18 ] Available from: https://doi.org/10.1038/s41375-021-01352-9
Vancouver
Adamiak M, Bujko K, Thapa A, Pensato V, Janus KB, Ratajczak J, Davies DL, Ulrich H, Kucia M, Ratajczak MZ. The P2X4 purinergic receptor has emerged as a potent regulator of hematopoietic stem/progenitor cell mobilization and homing-a novel view of P2X4 and P2X7 receptor interaction in orchestrating stem cell trafficking [Internet]. Leukemia. 2022 ; 36( 1): 248-256.[citado 2026 abr. 18 ] Available from: https://doi.org/10.1038/s41375-021-01352-9
Artigo de periodico
Therapeutic targeting of the E3 ubiquitin ligase SKP2 in T-ALL (2020)
Rodriguez, Sonia; Abundis, Christina; Boccalatte, Francesco; Mehrotra, Purvi; Chiang, Mark Y.; Yui, Mary A.; Wang, Lin; Zhang, Huajia; Zollman, Amy; Bonfim-Silva, Ricardo ; Kloetgen, Andreas; Palmer, Joycelynne; Sandusky, George; Wunderlich, Mark; Kaplan, Mark H.; Mulloy, James C.; Marcucci, Guido; Aifantis, Iannis; Cardoso, Angelo A.; Carlesso, Nadia
Source: Leukemia. Unidade: FMRP
Subjects: APOPTOSE, REGULAÇÃO GÊNICA, LEUCEMIA, PROTEÍNAS QUINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUEZ, Sonia et al. Therapeutic targeting of the E3 ubiquitin ligase SKP2 in T-ALL. Leukemia, v. 34, n. 5, p. 1241-1252, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41375-019-0653-z. Acesso em: 18 abr. 2026.
APA
Rodriguez, S., Abundis, C., Boccalatte, F., Mehrotra, P., Chiang, M. Y., Yui, M. A., et al. (2020). Therapeutic targeting of the E3 ubiquitin ligase SKP2 in T-ALL. Leukemia, 34( 5), 1241-1252. doi:10.1038/s41375-019-0653-z
NLM
Rodriguez S, Abundis C, Boccalatte F, Mehrotra P, Chiang MY, Yui MA, Wang L, Zhang H, Zollman A, Bonfim-Silva R, Kloetgen A, Palmer J, Sandusky G, Wunderlich M, Kaplan MH, Mulloy JC, Marcucci G, Aifantis I, Cardoso AA, Carlesso N. Therapeutic targeting of the E3 ubiquitin ligase SKP2 in T-ALL [Internet]. Leukemia. 2020 ; 34( 5): 1241-1252.[citado 2026 abr. 18 ] Available from: https://doi.org/10.1038/s41375-019-0653-z
Vancouver
Rodriguez S, Abundis C, Boccalatte F, Mehrotra P, Chiang MY, Yui MA, Wang L, Zhang H, Zollman A, Bonfim-Silva R, Kloetgen A, Palmer J, Sandusky G, Wunderlich M, Kaplan MH, Mulloy JC, Marcucci G, Aifantis I, Cardoso AA, Carlesso N. Therapeutic targeting of the E3 ubiquitin ligase SKP2 in T-ALL [Internet]. Leukemia. 2020 ; 34( 5): 1241-1252.[citado 2026 abr. 18 ] Available from: https://doi.org/10.1038/s41375-019-0653-z
Artigo de periodico
Novel evidence that extracellular nucleotides and purinergic signaling induce innate immunity-mediated mobilization of hematopoietic stem/progenitor cells (2018)
Adamiak, Mateusz; Bujko, Kamila; Cymer, Monika; Plonka, Monika; Glaser, Talita; Kucia, Magda ; Ratajczak, Janina; Ulrich, Henning ; Latif, Ahmed Abdel; Ratajczak, Mariusz Z
Source: Leukemia. Unidade: IQ
Subjects: CÉLULAS-TRONCO, NUCLEOTÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ADAMIAK, Mateusz et al. Novel evidence that extracellular nucleotides and purinergic signaling induce innate immunity-mediated mobilization of hematopoietic stem/progenitor cells. Leukemia, v. 32, p. 1920-1931, 2018Tradução . . Disponível em: https://doi.org/10.1038/s41375-018-0122-0. Acesso em: 18 abr. 2026.
APA
Adamiak, M., Bujko, K., Cymer, M., Plonka, M., Glaser, T., Kucia, M., et al. (2018). Novel evidence that extracellular nucleotides and purinergic signaling induce innate immunity-mediated mobilization of hematopoietic stem/progenitor cells. Leukemia, 32, 1920-1931. doi:10.1038/s41375-018-0122-0
NLM
Adamiak M, Bujko K, Cymer M, Plonka M, Glaser T, Kucia M, Ratajczak J, Ulrich H, Latif AA, Ratajczak MZ. Novel evidence that extracellular nucleotides and purinergic signaling induce innate immunity-mediated mobilization of hematopoietic stem/progenitor cells [Internet]. Leukemia. 2018 ; 32 1920-1931.[citado 2026 abr. 18 ] Available from: https://doi.org/10.1038/s41375-018-0122-0
Vancouver
Adamiak M, Bujko K, Cymer M, Plonka M, Glaser T, Kucia M, Ratajczak J, Ulrich H, Latif AA, Ratajczak MZ. Novel evidence that extracellular nucleotides and purinergic signaling induce innate immunity-mediated mobilization of hematopoietic stem/progenitor cells [Internet]. Leukemia. 2018 ; 32 1920-1931.[citado 2026 abr. 18 ] Available from: https://doi.org/10.1038/s41375-018-0122-0
Artigo de periodico
Identification of target genes using gene expression profile of granulocytes from patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors (2014)
Mascarenhas, Cintia do Couto; Cunha, Anderson Ferreira da; Brugnerotto, Ana Flávia; Gambero, Sheley; Almeida, Maria Helena de; Carazzolle, Marcelo F.; Pagnano, Katia Borgia Barbosa; Traina, Fabiola; Costa, Fernando Ferreira da; Souza, Carmino Antonio de
Source: Leukemia. Unidade: FMRP
Subjects: ANTINEOPLÁSICOS (FARMACOLOGIA), EXPRESSÃO GÊNICA, GRANULÓCITOS (EFEITOS DE DROGAS), LEUCEMIA MIELOIDE (GENÉTICA;METABOLISMO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MASCARENHAS, Cintia do Couto et al. Identification of target genes using gene expression profile of granulocytes from patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors. Leukemia, v. 55, n. 8, p. 1861-1869, 2014Tradução . . Disponível em: https://doi.org/10.3109/10428194.2013.855311. Acesso em: 18 abr. 2026.
APA
Mascarenhas, C. do C., Cunha, A. F. da, Brugnerotto, A. F., Gambero, S., Almeida, M. H. de, Carazzolle, M. F., et al. (2014). Identification of target genes using gene expression profile of granulocytes from patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors. Leukemia, 55( 8), 1861-1869. doi:10.3109/10428194.2013.855311
NLM
Mascarenhas C do C, Cunha AF da, Brugnerotto AF, Gambero S, Almeida MH de, Carazzolle MF, Pagnano KBB, Traina F, Costa FF da, Souza CA de. Identification of target genes using gene expression profile of granulocytes from patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors [Internet]. Leukemia. 2014 ; 55( 8): 1861-1869.[citado 2026 abr. 18 ] Available from: https://doi.org/10.3109/10428194.2013.855311
Vancouver
Mascarenhas C do C, Cunha AF da, Brugnerotto AF, Gambero S, Almeida MH de, Carazzolle MF, Pagnano KBB, Traina F, Costa FF da, Souza CA de. Identification of target genes using gene expression profile of granulocytes from patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors [Internet]. Leukemia. 2014 ; 55( 8): 1861-1869.[citado 2026 abr. 18 ] Available from: https://doi.org/10.3109/10428194.2013.855311
Artigo de periodico
Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms (2014)
Traina, Fabiola; Visconte, V.; Elson, P.; Tabarroki, A.; Jankowska, A. M.; Hasrouni, E.; Sugimoto, Y.; Szpurka, H.; Makishima, H.; O'Keefe, C. L.; Sekeres, M. A.; Advani, A. S.; Kalaycio, M.; Copelan, E. A.; Saunthararajah, Y.; Saad, S. T. Olalla; Maciejewski, J. P.; Tiu, R. V.
Source: Leukemia. Unidade: FMRP
Subjects: INIBIDORES DE ENZIMAS (FARMACOLOGIA), DOENÇAS DA MEDULA ESPINHAL (PATOLOGIA), BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TRAINA, Fabiola et al. Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms. Leukemia, v. 28, n. 1, p. 78-87, 2014Tradução . . Disponível em: https://doi.org/10.1038/leu.2013.269. Acesso em: 18 abr. 2026.
APA
Traina, F., Visconte, V., Elson, P., Tabarroki, A., Jankowska, A. M., Hasrouni, E., et al. (2014). Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms. Leukemia, 28( 1), 78-87. doi:10.1038/leu.2013.269
NLM
Traina F, Visconte V, Elson P, Tabarroki A, Jankowska AM, Hasrouni E, Sugimoto Y, Szpurka H, Makishima H, O'Keefe CL, Sekeres MA, Advani AS, Kalaycio M, Copelan EA, Saunthararajah Y, Saad STO, Maciejewski JP, Tiu RV. Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms [Internet]. Leukemia. 2014 ; 28( 1): 78-87.[citado 2026 abr. 18 ] Available from: https://doi.org/10.1038/leu.2013.269
Vancouver
Traina F, Visconte V, Elson P, Tabarroki A, Jankowska AM, Hasrouni E, Sugimoto Y, Szpurka H, Makishima H, O'Keefe CL, Sekeres MA, Advani AS, Kalaycio M, Copelan EA, Saunthararajah Y, Saad STO, Maciejewski JP, Tiu RV. Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms [Internet]. Leukemia. 2014 ; 28( 1): 78-87.[citado 2026 abr. 18 ] Available from: https://doi.org/10.1038/leu.2013.269
Artigo de periodico
Short telomeres result in chromosomal instability in hematopoietic cells and precede malignant evolution in human aplastic anemia (2012)
Calado, Rodrigo Tocantins; Cooper, J. N.; Nash, H. M. Padilla; Sloand, E. M.; Wu, C. O.; Scheinberg, P.; Ried, T.; Young, N. S.
Source: Leukemia. Unidade: FMRP
Subjects: ANEMIA, TRANSFORMAÇÃO CELULAR NEOPLÁSICA (GENÉTICA), HEMATOPOESE (METABOLISMO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CALADO, Rodrigo Tocantins et al. Short telomeres result in chromosomal instability in hematopoietic cells and precede malignant evolution in human aplastic anemia. Leukemia, v. 26, p. 700-707, 2012Tradução . . Disponível em: https://doi.org/10.1038/leu.2011.272. Acesso em: 18 abr. 2026.
APA
Calado, R. T., Cooper, J. N., Nash, H. M. P., Sloand, E. M., Wu, C. O., Scheinberg, P., et al. (2012). Short telomeres result in chromosomal instability in hematopoietic cells and precede malignant evolution in human aplastic anemia. Leukemia, 26, 700-707. doi:10.1038/leu.2011.272
NLM
Calado RT, Cooper JN, Nash HMP, Sloand EM, Wu CO, Scheinberg P, Ried T, Young NS. Short telomeres result in chromosomal instability in hematopoietic cells and precede malignant evolution in human aplastic anemia [Internet]. Leukemia. 2012 ; 26 700-707.[citado 2026 abr. 18 ] Available from: https://doi.org/10.1038/leu.2011.272
Vancouver
Calado RT, Cooper JN, Nash HMP, Sloand EM, Wu CO, Scheinberg P, Ried T, Young NS. Short telomeres result in chromosomal instability in hematopoietic cells and precede malignant evolution in human aplastic anemia [Internet]. Leukemia. 2012 ; 26 700-707.[citado 2026 abr. 18 ] Available from: https://doi.org/10.1038/leu.2011.272
Artigo de periodico
(+)'alfa'-Tocopheryl succinate inhibits the mitochondrial respiratory chain complex 1 and is as effective as arsenic trioxide or ATRA against promyelocytic Leukemia in vivo (2012)
Santos, G. A. S.; Abreu e Lima, R. S.; Pestana, C. R.; Lima, A. S. G.; Scheucher, P. S.; Thomé, C. H.; Gimenes Teixeira, H. L.; Santana-Lemos, Bárbara Amélia Aparecida; Lucena-Araújo, A. R.; Rodrigues, F. P.; Nasr, R.; Uyemura, Sérgio Akira; Falcao, Roberto Passetto; Thé, H. de; Pandolfi, P. P.; Curti, Carlos; Rego, Eduardo Magalhaes
Source: Leukemia. Unidades: FMRP, FCFRP
Subjects: ANTINEOPLÁSICOS (FARMACOLOGIA;APLICAÇÕES TERAPÊUTICAS), ANTIOXIDANTES, APOPTOSE (EFEITOS DE DROGAS), MODELOS ANIMAIS DE DOENÇAS, TRANSPORTE DE ELÉTRONS (ANTAGONISTAS E INIBIDORES), LEUCEMIA, MITOCÔNDRIAS (EFEITOS DE DROGAS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, G. A. S. et al. (+)'alfa'-Tocopheryl succinate inhibits the mitochondrial respiratory chain complex 1 and is as effective as arsenic trioxide or ATRA against promyelocytic Leukemia in vivo. Leukemia, v. 26, n. 3, p. 451-460, 2012Tradução . . Disponível em: https://doi.org/10.1038/leu.2011.216. Acesso em: 18 abr. 2026.
APA
Santos, G. A. S., Abreu e Lima, R. S., Pestana, C. R., Lima, A. S. G., Scheucher, P. S., Thomé, C. H., et al. (2012). (+)'alfa'-Tocopheryl succinate inhibits the mitochondrial respiratory chain complex 1 and is as effective as arsenic trioxide or ATRA against promyelocytic Leukemia in vivo. Leukemia, 26( 3), 451-460. doi:10.1038/leu.2011.216
NLM
Santos GAS, Abreu e Lima RS, Pestana CR, Lima ASG, Scheucher PS, Thomé CH, Gimenes Teixeira HL, Santana-Lemos BAA, Lucena-Araújo AR, Rodrigues FP, Nasr R, Uyemura SA, Falcao RP, Thé H de, Pandolfi PP, Curti C, Rego EM. (+)'alfa'-Tocopheryl succinate inhibits the mitochondrial respiratory chain complex 1 and is as effective as arsenic trioxide or ATRA against promyelocytic Leukemia in vivo [Internet]. Leukemia. 2012 ; 26( 3): 451-460.[citado 2026 abr. 18 ] Available from: https://doi.org/10.1038/leu.2011.216
Vancouver
Santos GAS, Abreu e Lima RS, Pestana CR, Lima ASG, Scheucher PS, Thomé CH, Gimenes Teixeira HL, Santana-Lemos BAA, Lucena-Araújo AR, Rodrigues FP, Nasr R, Uyemura SA, Falcao RP, Thé H de, Pandolfi PP, Curti C, Rego EM. (+)'alfa'-Tocopheryl succinate inhibits the mitochondrial respiratory chain complex 1 and is as effective as arsenic trioxide or ATRA against promyelocytic Leukemia in vivo [Internet]. Leukemia. 2012 ; 26( 3): 451-460.[citado 2026 abr. 18 ] Available from: https://doi.org/10.1038/leu.2011.216
Artigo de periodico
Association of drug metabolism gene polymorphisms with toxities, graft-versus-host disease and survival after HLA-identical sibling hematopoietic stem cell transplantation for patients with leukemia (2009)
Rocha, Vanderson; Porcher, Raphael; Fernandes, J. F.; Filion, Alain; Bittencourt, H.; Silva Júnior, Wilson Araújo da; Vilela, G.; Zanette, Dalila Luciola; Ferry, Claude; Larghero, J.; Devergie, Agnes; Ribaud, P.; Skvortsova, Y.; Tamouza, R.; Gluckman, Eliane; Socie, Gerard; Zago, Marco Antônio
Source: Leukemia. Unidade: FMRP
Subjects: CÉLULAS-TRONCO (TRANSPLANTE), LEUCEMIA, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROCHA, Vanderson et al. Association of drug metabolism gene polymorphisms with toxities, graft-versus-host disease and survival after HLA-identical sibling hematopoietic stem cell transplantation for patients with leukemia. Leukemia, v. 23, n. 3, p. 545-556, 2009Tradução . . Disponível em: https://doi.org/10.1038/leu.2008.323. Acesso em: 18 abr. 2026.
APA
Rocha, V., Porcher, R., Fernandes, J. F., Filion, A., Bittencourt, H., Silva Júnior, W. A. da, et al. (2009). Association of drug metabolism gene polymorphisms with toxities, graft-versus-host disease and survival after HLA-identical sibling hematopoietic stem cell transplantation for patients with leukemia. Leukemia, 23( 3), 545-556. doi:10.1038/leu.2008.323
NLM
Rocha V, Porcher R, Fernandes JF, Filion A, Bittencourt H, Silva Júnior WA da, Vilela G, Zanette DL, Ferry C, Larghero J, Devergie A, Ribaud P, Skvortsova Y, Tamouza R, Gluckman E, Socie G, Zago MA. Association of drug metabolism gene polymorphisms with toxities, graft-versus-host disease and survival after HLA-identical sibling hematopoietic stem cell transplantation for patients with leukemia [Internet]. Leukemia. 2009 ; 23( 3): 545-556.[citado 2026 abr. 18 ] Available from: https://doi.org/10.1038/leu.2008.323
Vancouver
Rocha V, Porcher R, Fernandes JF, Filion A, Bittencourt H, Silva Júnior WA da, Vilela G, Zanette DL, Ferry C, Larghero J, Devergie A, Ribaud P, Skvortsova Y, Tamouza R, Gluckman E, Socie G, Zago MA. Association of drug metabolism gene polymorphisms with toxities, graft-versus-host disease and survival after HLA-identical sibling hematopoietic stem cell transplantation for patients with leukemia [Internet]. Leukemia. 2009 ; 23( 3): 545-556.[citado 2026 abr. 18 ] Available from: https://doi.org/10.1038/leu.2008.323
Artigo de periodico
The higher expression of 'alfa' and 'beta' isoforms of the human glucocorticoid receptor in leukemic B-progenitors compared to normal CD'10 POT +' BM cells does not correlate with methylprednisolone-induced apoptosis (2004)
Albuquerque, L. M. M.; Garcia, Aglair Bergamo; Mengel, J. O.; Falcão, Roberto Passetto; Castro, Margaret de; Rego, Eduardo Magalhães
Source: Leukemia. Unidade: FMRP
Assunto: LEUCEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALBUQUERQUE, L. M. M. et al. The higher expression of 'alfa' and 'beta' isoforms of the human glucocorticoid receptor in leukemic B-progenitors compared to normal CD'10 POT +' BM cells does not correlate with methylprednisolone-induced apoptosis. Leukemia, v. 18, p. 890-892, 2004Tradução . . Acesso em: 18 abr. 2026.
APA
Albuquerque, L. M. M., Garcia, A. B., Mengel, J. O., Falcão, R. P., Castro, M. de, & Rego, E. M. (2004). The higher expression of 'alfa' and 'beta' isoforms of the human glucocorticoid receptor in leukemic B-progenitors compared to normal CD'10 POT +' BM cells does not correlate with methylprednisolone-induced apoptosis. Leukemia, 18, 890-892.
NLM
Albuquerque LMM, Garcia AB, Mengel JO, Falcão RP, Castro M de, Rego EM. The higher expression of 'alfa' and 'beta' isoforms of the human glucocorticoid receptor in leukemic B-progenitors compared to normal CD'10 POT +' BM cells does not correlate with methylprednisolone-induced apoptosis. Leukemia. 2004 ; 18 890-892.[citado 2026 abr. 18 ]
Vancouver
Albuquerque LMM, Garcia AB, Mengel JO, Falcão RP, Castro M de, Rego EM. The higher expression of 'alfa' and 'beta' isoforms of the human glucocorticoid receptor in leukemic B-progenitors compared to normal CD'10 POT +' BM cells does not correlate with methylprednisolone-induced apoptosis. Leukemia. 2004 ; 18 890-892.[citado 2026 abr. 18 ]
Artigo de periodico-carta/editorial
Age-related changes of P-glycoprotein-mediated rhodamine 123 efflux in normal human bone marrow hematopoietic stem cells [Carta] (2003)
Falcão, Roberto Passetto
Source: Leukemia. Unidade: FMRP
Subjects: HEMATOLOGIA, BIOQUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FALCÃO, Roberto Passetto. Age-related changes of P-glycoprotein-mediated rhodamine 123 efflux in normal human bone marrow hematopoietic stem cells [Carta]. Leukemia. Baltimore: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 18 abr. 2026. , 2003
APA
Falcão, R. P. (2003). Age-related changes of P-glycoprotein-mediated rhodamine 123 efflux in normal human bone marrow hematopoietic stem cells [Carta]. Leukemia. Baltimore: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Falcão RP. Age-related changes of P-glycoprotein-mediated rhodamine 123 efflux in normal human bone marrow hematopoietic stem cells [Carta]. Leukemia. 2003 ;17 816-818.[citado 2026 abr. 18 ]
Vancouver
Falcão RP. Age-related changes of P-glycoprotein-mediated rhodamine 123 efflux in normal human bone marrow hematopoietic stem cells [Carta]. Leukemia. 2003 ;17 816-818.[citado 2026 abr. 18 ]
Artigo de periodico
A case of TCR "GAMA DELTA POSITIVO" T-ALL with cross-lineage CD19 expression (1999)
Pereira, J.; Melo, N. B.; Buccheri, V.; Tutiya, I. E.; Beitler, B.; Llacer, Pedro Enrique Dorlhiac; Chamone, Dalton de Alencar Fischer
Source: Leukemia. Unidade: FM
Assunto: LEUCEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, J. et al. A case of TCR "GAMA DELTA POSITIVO" T-ALL with cross-lineage CD19 expression. Leukemia, v. 13, n. 5, p. 824-825, 1999Tradução . . Acesso em: 18 abr. 2026.
APA
Pereira, J., Melo, N. B., Buccheri, V., Tutiya, I. E., Beitler, B., Llacer, P. E. D., & Chamone, D. de A. F. (1999). A case of TCR "GAMA DELTA POSITIVO" T-ALL with cross-lineage CD19 expression. Leukemia, 13( 5), 824-825.
NLM
Pereira J, Melo NB, Buccheri V, Tutiya IE, Beitler B, Llacer PED, Chamone D de AF. A case of TCR "GAMA DELTA POSITIVO" T-ALL with cross-lineage CD19 expression. Leukemia. 1999 ; 13( 5): 824-825.[citado 2026 abr. 18 ]
Vancouver
Pereira J, Melo NB, Buccheri V, Tutiya IE, Beitler B, Llacer PED, Chamone D de AF. A case of TCR "GAMA DELTA POSITIVO" T-ALL with cross-lineage CD19 expression. Leukemia. 1999 ; 13( 5): 824-825.[citado 2026 abr. 18 ]
Artigo de periodico
Lack of BCR/ABL rearrangement in acute and chronic T cell leukemias (1997)
Simões, Belinda Pinto; Scaffo, M H S; Falcão, Roberto Passetto
Source: Leukemia. Unidade: FMRP
Assunto: HEMATOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SIMÕES, Belinda Pinto e SCAFFO, M H S e FALCÃO, Roberto Passetto. Lack of BCR/ABL rearrangement in acute and chronic T cell leukemias. Leukemia, v. 11, n. 9, p. 1595-1596, 1997Tradução . . Disponível em: https://doi.org/10.1038/sj.leu.2400764. Acesso em: 18 abr. 2026.
APA
Simões, B. P., Scaffo, M. H. S., & Falcão, R. P. (1997). Lack of BCR/ABL rearrangement in acute and chronic T cell leukemias. Leukemia, 11( 9), 1595-1596. doi:10.1038/sj.leu.2400764
NLM
Simões BP, Scaffo MHS, Falcão RP. Lack of BCR/ABL rearrangement in acute and chronic T cell leukemias [Internet]. Leukemia. 1997 ; 11( 9): 1595-1596.[citado 2026 abr. 18 ] Available from: https://doi.org/10.1038/sj.leu.2400764
Vancouver
Simões BP, Scaffo MHS, Falcão RP. Lack of BCR/ABL rearrangement in acute and chronic T cell leukemias [Internet]. Leukemia. 1997 ; 11( 9): 1595-1596.[citado 2026 abr. 18 ] Available from: https://doi.org/10.1038/sj.leu.2400764

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Funding Agencies

Indexado em

Non normalized affiliation